Roy Larimer

Visionary Pharmaceuticals (United States)

Papers

1

Total Citations

26

H-Index

1

About

Roy Larimer’s research sits at the intersection of biodiversity informatics and taxonomic practice, where he has pioneered the concept of nomenclatural benchmarking—the periodic recalibration of species names to align with evolving species theories. His landmark 2012 paper, “Nomenclatural benchmarking: the roles of digital typification and telemicroscopy” (26 citations), introduced a framework for ensuring the accurate and consistent use of Linnaean binominals as species boundaries shift. Larimer’s key contribution lies in demonstrating how digital typification and telemicroscopy can democratize access to type specimens, reducing the need for costly, expert-led physical examinations. This work has practical implications for taxonomy, enabling more rigorous and reproducible species identification in an era of rapid biodiversity loss. While his citation count reflects a specialized audience, his ideas have influenced discussions on digital curation and taxonomic stability. Larimer’s achievements include advancing a methodological standard that bridges traditional taxonomy with modern digital tools, making him a notable voice in the ongoing effort to modernize biological nomenclature for the 21st century.

Research Focus

Key Achievements

1
H-Index
1
Papers
26
Total Citations
26
Avg Citations/Paper
🏆 Most Cited Paper
Nomenclatural benchmarking: the roles of digital typification and telemicroscopy
26 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Visionary Pharmaceuticals (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago